Kadimastem Stock Return On Asset

KDST Stock  ILA 1,189  14.00  1.19%   
Kadimastem fundamentals help investors to digest information that contributes to Kadimastem's financial success or failures. It also enables traders to predict the movement of Kadimastem Stock. The fundamental analysis module provides a way to measure Kadimastem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kadimastem stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Kadimastem Company Return On Asset Analysis

Kadimastem's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Kadimastem Return On Asset

    
  -0.75  
Most of Kadimastem's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kadimastem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Kadimastem has a Return On Asset of -0.7485. This is 91.45% lower than that of the Biotechnology sector and 96.83% lower than that of the Health Care industry. The return on asset for all Israel stocks is notably higher than that of the company.

Kadimastem Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kadimastem's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kadimastem could also be used in its relative valuation, which is a method of valuing Kadimastem by comparing valuation metrics of similar companies.
Kadimastem is currently under evaluation in return on asset category among its peers.

Kadimastem Fundamentals

About Kadimastem Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Kadimastem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kadimastem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kadimastem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Kadimastem Stock

Kadimastem financial ratios help investors to determine whether Kadimastem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kadimastem with respect to the benefits of owning Kadimastem security.